The difference in loci bound by ER in breast and endometrial cancer cells was first observed in cell lines [78, 82] and later confirmed in patient tissues [83] where 15–30% of ER binding sites are shared between breast cancer and endometrial cancer cells. Here, ESR1 is linked to breast cancer.